Original Research
Accepted on 09 Jul 2025
Nomogram-based risk stratification to analyze the value of receiving postoperative adjuvant therapy after neoadjuvant immunochemotherapy for patients with locally advanced esophageal squamous carcinoma.
in Cancer Immunity and Immunotherapy